Clinical Trial Update: Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update of suberoylanilide hydroxamic acid (vorinostat) in patients with advanced cancer has been completed. The document summarizes safety and pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Vorinostat (vorinostat)
• Zolinza (vorinostat)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cancer | Phase 1 | Status: COMPLETED